4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1111L | Tirzepatide Acetate(2023788-19-2 free base) | Glucagon Receptor | |
Tirzepatide acetate is a dual GIP / GLP-1 receptor agonist. | |||
TP1111L1 | Tirzepatide sodium salt | LY-3298176 sodium salt,Tirzepatide sodium salt(2023788-19-2 free base) | Glucagon Receptor |
Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity. | |||
TP1111 | Tirzepatide | LY-3298176 | Glucagon Receptor |
Tirzepatide (LY-3298176) is a dual agonist of glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor with neuroprotective activity for the study of diabetes and obesity. | |||
T76006 | Tirzepatide TFA | Tirzepatide TFA(2023788-19-2 free base),LY3298176 TFA | |
Tirzepatide TFA (LY3298176 TFA), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is under development for type 2 diabetes treatment [1]. |